NOT 'New' issue! This is from 2019 AMA https://t.co/6es0l11JLR
603 followers
1,497 followers
2,019 followers
RT @JournalofEthics: An abbreviated pathway to approval for biosimilars was created by Congress in 2010. So why are they still not living u…
2,019 followers
2019 "This article examines the current landscape of the biosimilar market, characterizes tactics employed by biologics manufacturers to delay market entry and deter prescribing of biosimilars, and assesses ethical issues related to increasing the adoption